StrokeNet Thrombectomy Endovascular Platform
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT06289985
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Endovascular thrombectomy with any FDA-approved category POL or NRY device — DEVICEEndovascular thrombectomy with any FDA-approved category POL or NRY device - Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL), and/or Catheter, Thrombus Retriever (NRY)
- Medical Management — OTHERMedical Management (MM) may involve any combination of the following: intravenous thrombolysis, antiplatelets, anti-hypertensives, cholesterol-lowering medications, and rehabilitative care.
Study Details
STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Key Dates
- Start date
- Jan 31, 2025
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 1,600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Other: Endovascular Therapy (EVT) Indication Expansion Domain: Low NIHSS StrataAdult patients with acute cerebral ischemia within 24 hours of last known well who have large vessel occlusion (LVO) and mild deficits/low NIHSS (NIHSS 0-5) will be randomized to receive one of two strategies: * Endovascular Therapy (EVT) * Medical Management (MM)
- Other: Endovascular Therapy (EVT) Indication Expansion Domain: Medium/Distal Occlusions StrataAdult patients with acute cerebral ischemia within 24 hours of last known who have Medium Vessel Occlusion (MVO) with Non-dominant/Co-dominant M2 occlusion or Distal Medium Vessel Occlusion (DMVO) patients with M3 occlusion will be randomized to receive one of two strategies: * Endovascular Therapy (EVT) * Medical Management (MM)
Primary Outcome Measure
Global disability measured by Modified Rankin Score [ Time Frame: 90-day ]
Central Contacts
- Jordan Elm843-876-1605
Locations (41)
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Related Studies
- Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular DisordersRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Verapamil for Neuroprotection in StrokePHASE1/PHASE2 · Recruiting · Global Neurosciences Institute · Atlantic City, New Jersey
- The Recovery in Stroke Using PAP StudyRecruiting · Yale University · New Haven, Connecticut